Complete Question Bank

HESI LPN · HESI LPN Pharmacology · HESI Drugs for diabetes

Full Question & Rationale Repository

Showing all 5 practice questions with expert explanatory rationales.

Question 1 of 5

Guargum limits post-prandial glycaemia by

A. Inhibiting intestinal brush border ÃƒÅ½Ã‚Â± glucosidases

B. Slowing carbohydrate absorption from intestine

C. Releasing incretins from the intestine

D. Promoting uptake of glucose into skeletal muscles

Correct Answer: Slowing carbohydrate absorption from intestine

Question 2 of 5

Preferred route of insulin is

A. Oral

B. Subcutaneous

C. Sublingual

D. Enteric coated tabs

Correct Answer: Subcutaneous

Question 3 of 5

Insulin resistance can be overcome by the use of

A. Corticosteroids

B. Tolbutamide

C. Protamine

D. Monocomponent insulin preparations

Correct Answer: Monocomponent insulin preparations

Question 4 of 5

Sulfonylureas are a primary mode of therapy in the treatment of

A. Insulin-dependent (type 1) diabetes mellitus (IDDM) patients

B. Diabetic patients experiencing severe hepatic or renal dysfunction

C. Diabetic pregnant women

D. Non-insulin-dependent (type 2) DM patients

Correct Answer: Non-insulin-dependent (type 2) DM patients

Question 5 of 5

The second generation sulfonylurea hypoglycaemics differ from the first generation one in that they

A. Are more potent

B. Are longer acting

C. Do not lower blood sugar in nondiabetic subject

D. Are less prone to cause hypoglycaemic reaction

Correct Answer: Are more potent

Ready to Guarantee Your Result?

Start Your HESI LPN Preparation Journey Today

Access over 300,000 verified practice questions, comprehensive subject diagnostic exams, and timed clinical simulations engineered for success.